(IOVA) Iovance - Performance -87% in 12m
Compare IOVA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-88.61%
#154 in Group
Rel. Strength
4.88%
#7569 in Universe
Total Return 12m
-86.99%
#147 in Group
Total Return 5y
-95.29%
#115 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -42.39%
(?) Percentile in Group
12m Total Return: IOVA (-87%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: IOVA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IOVA
Total Return (including Dividends) | IOVA | XBI | S&P 500 |
---|---|---|---|
1 Month | -46.48% | 2.02% | 2.87% |
3 Months | -67.11% | -15.44% | -6.42% |
12 Months | -86.99% | -14.02% | 9.87% |
5 Years | -95.29% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | IOVA | XBI | S&P 500 |
1 Month | 10.9% | 57% | 89.4% |
3 Months | -83.5% | -82.3% | -72% |
12 Months | -73.2% | -53.1% | 49.3% |
5 Years | -81.3% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #131 | -47.5% | -48.0% |
3 Month | #164 | -61.1% | -64.9% |
12 Month | #146 | -84.9% | -88.2% |
5 Years | #115 | -93.6% | -97.7% |
FAQs
Does IOVA Iovance outperforms the market?
No,
over the last 12 months IOVA made -86.99%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months IOVA made -67.11%, while XBI made -15.44%.
Over the last 3 months IOVA made -67.11%, while XBI made -15.44%.
Performance Comparison IOVA vs Indeces and Sectors
IOVA vs. Indices IOVA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -49.6% | -49.4% | -78.4% | -96.9% |
US NASDAQ 100 | QQQ | -49.8% | -51.2% | -78.8% | -98.3% |
US Dow Jones Industrial 30 | DIA | -49.9% | -48.1% | -77.4% | -93.4% |
German DAX 40 | DAX | -51.7% | -65.8% | -104% | -112% |
Shanghai Shenzhen CSI 300 | CSI 300 | -50.2% | -52.8% | -77.7% | -92.6% |
Hongkong Hang Seng | HSI | -53.1% | -62.7% | -87.9% | -99.1% |
India NIFTY 50 | INDA | -47.2% | -48.8% | -80.3% | -89.3% |
Brasil Bovespa | EWZ | -51.6% | -58.0% | -87.6% | -80.5% |
IOVA vs. Sectors IOVA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -49.8% | -50.2% | -84.6% | -107% |
Consumer Discretionary | XLY | -50.5% | -50.0% | -76.2% | -101% |
Consumer Staples | XLP | -49.2% | -48.5% | -85.3% | -94.6% |
Energy | XLE | -50.6% | -46.6% | -72.4% | -77.2% |
Financial | XLF | -50.2% | -52.1% | -84.3% | -109% |
Health Care | XLV | -45.8% | -42.1% | -73.2% | -81.1% |
Industrial | XLI | -51.1% | -53.9% | -79.4% | -97.0% |
Materials | XLB | -49.6% | -51.2% | -74.4% | -81.0% |
Real Estate | XLRE | -49.2% | -52.6% | -80.8% | -100% |
Technology | XLK | -50.5% | -53.2% | -76.2% | -94.0% |
Utilities | XLU | -50.6% | -52.1% | -86.2% | -103% |
Aerospace & Defense | XAR | -50.1% | -55.8% | -87.7% | -112% |
Biotech | XBI | -41.5% | -48.5% | -57.4% | -73.0% |
Homebuilder | XHB | -49.1% | -49.6% | -64.8% | -77.2% |
Retail | XRT | -49.7% | -50.1% | -72.1% | -82.7% |